| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.62▼ | 3.62▼ | 3.62▼ | 3.23▼ | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Monday, July 15, 2019 01:01 PM
LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the ...
|
|
Monday, July 15, 2019 09:01 AM
LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the ...
|
|
Monday, July 15, 2019 02:01 AM
LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/07/19 | 3.15 | 3.22 | 2.75 | 3.18 | 18,153 |
| 19/07/19 | 3.10 | 3.20 | 3.11 | 3.15 | 6,793 |
| 18/07/19 | 3.20 | 3.204 | 2.93 | 3.12 | 49,780 |
| 17/07/19 | 3.34 | 3.34 | 3.34 | 3.34 | 1,995 |
| 16/07/19 | 3.36 | 3.36 | 3.36 | 3.36 | 21,065 |
| 15/07/19 | 3.825 | 3.825 | 3.825 | 3.825 | 3,076 |
| 12/07/19 | 3.795 | 3.795 | 3.76 | 3.76 | 39,537 |
| 11/07/19 | 3.74 | 3.90 | 3.74 | 3.90 | 126,127 |
| 10/07/19 | 4.78 | 4.99 | 4.17 | 4.22 | 249,184 |
|
|
||||
|
|
||||
|
|